Evidence map›Paper›PMID 30325025›Full record

ArticleThe Laryngoscope2018

Objective and subjective hyposalivation after treatment for head and neck cancer: Long-term outcomes.

Ilya Likhterov, Meng Ru, Cindy Ganz, Mark L Urken, Raymond Chai, Devin Okay, Jerry Liu, Robert Stewart, Bruce Culliney, Daisy Palacios and 1 more

Abstract read
In one paragraph

Article in The Laryngoscope, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Late laryngeal dysfunction in head and neck cancer survivors.Laryngoscope investigative otolaryngology · 2023
    Article
  9. Development and Evaluation of the Psychometric Properties of the Tamil Version of Eating Assessment Tool - 10 (EAT-10): Preliminary Findings from Persons with Head and Neck Cancer.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2023
    Article
  10. Oral health-related quality of life after radiation therapy for head and neck cancer: the OraRad study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Observational
  11. Taste alterations and oral discomfort in patients receiving chemotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  12. Observational
  13. Article
  14. Article
  15. Clinical and sociodemographic factors that affect the quality of life of survivors of head and neck cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Article
  16. European journal of nuclear medicine and molecular imaging · 2020
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Ilya LikhterovThyroid, Head and Neck Cancer (THANC) Foundation, New York, New York.
Meng RuDepartment of Population Health Science and Policy.
Cindy GanzThyroid, Head and Neck Cancer (THANC) Foundation, New York, New York.
Mark L UrkenThyroid, Head and Neck Cancer (THANC) Foundation, New York, New York.
Raymond ChaiThyroid, Head and Neck Cancer (THANC) Foundation, New York, New York.
Devin OkayThyroid, Head and Neck Cancer (THANC) Foundation, New York, New York.
Jerry LiuThyroid, Head and Neck Cancer (THANC) Foundation, New York, New York.
Robert StewartThyroid, Head and Neck Cancer (THANC) Foundation, New York, New York.
Bruce CullineyDepartment of Radiation Oncology.
Daisy PalaciosDepartment of Radiation Oncology.
Cathy L LazarusThyroid, Head and Neck Cancer (THANC) Foundation, New York, New York.ORCID 0000-0002-1770-7753
Thyroid Head and Neck Cancer Foundation · USMount Sinai Health System · US

Funding

THE TISCH CANCER INSTITUTE - CANCER CENTER SUPPORT GRANTP30CA196521 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Deanna L Benson · 2015 to 2026
$35.4M
NCI NIH HHS P30 CA196521
6 · The paper itself

Abstract

objectives/hypothesisThis study examined saliva weight over time and its association with diet and patient-rated swallowing, dry mouth, sticky saliva, and dysgeusia quality of life in head and neck cancer (HNCA) patients treated with surgery plus adjuvant chemoradiotherapy (CRT), or primary CRT. STUDY

designProspective cohort study in an outpatient HNCA center setting.

methodsPatients were seen pretreatment, and 1, 3, 6, 12, 24, and 36 + months post-treatment. All had newly diagnosed oral, oropharynx, nasopharynx, larynx/hypopharynx cancer from 2010 to 2016 and were to undergo surgery + CRT or primary CRT. Stimulated saliva weight was assessed with the Saxon test. Diet, eating, dry mouth, and dysgeusia quality of life were assessed and correlated with saliva weight, treatment modality, and tumor site.

resultsSaliva weight decreased the most within the first 3 months across treatment groups, except for the surgery + CRT group, which continued to decline. Similar trends were seen by tumor site. Performance Status Scale (PSS) Normalcy of Diet and all quality-of-life scores declined following treatment. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Head and Neck-35 (EORTC QLQ-H&N35); Eating Assessment Tool (EAT-10); M. D. Anderson Dysphagia Inventory (MDADI) Composite, Global, and subdomain scores; and PSS Diet were significantly correlated with saliva weight.

conclusionsSaliva weight worsened post-treatment across groups and tumor site, with improvement by 36 + months. Saliva weight correlated with diet, eating quality of life and perception of dysgeusia across time points. Despite dose-sparing intensity-modulated radiation therapy, newer technologies are needed to preserve saliva production and maintain higher quality of life. LEVEL OF EVIDENCE: 2b Laryngoscope, 128:2732-2739, 2018.

Indexed as

Chemoradiotherapy, AdjuvantDeglutitionFemaleHead and Neck NeoplasmsHumansMaleMiddle AgedPostoperative ComplicationsPostoperative PeriodProspective StudiesQuality of LifeSalivaTime FactorsTreatment OutcomeXerostomiahead and neck cancerHyposalivationoutcomesquality of life

Identifiers

PMID30325025
PMCPMC6309704
OpenAlexW2897533165

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.